13F-HR filed by Ghost Tree Capital, LLC
Ghost Tree Capital, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 49 holding rows worth $426,439,000.
- Accession
- 0001387131-18-000604
- Filer
- CIK 1595851
- Filed
- 2018-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 49 entries on the cover page, a total value of $426,439,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $426,439,000 with VALUE read as thousands by filing date, 13F file number 028-16059. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 850,000 | $72,140,000 | thousands by filing date | put |
| IMMUNOMEDICS INC | 452907108 | COM | 1,538,000 | $24,854,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,300,000 | $21,008,000 | thousands by filing date | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 250,000 | $15,785,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 150,000 | $15,654,000 | thousands by filing date | call |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 230,000 | $15,143,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 115,000 | $13,753,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 325,000 | $12,789,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 75,000 | $12,269,000 | thousands by filing date | call |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 150,000 | $11,312,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 225,000 | $10,953,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 600,000 | $10,950,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 250,000 | $10,578,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 250,000 | $10,015,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 85,000 | $9,407,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 150,000 | $9,192,000 | thousands by filing date | call |
| ACCELERON PHARMA INC | 00434H108 | COM | 200,000 | $8,488,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 900,000 | $8,334,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 325,000 | $7,995,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 45,750 | $7,484,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 180,000 | $7,209,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 43,700 | $7,198,000 | thousands by filing date | put |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 150,000 | $6,857,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 100,000 | $6,800,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 200,000 | $6,436,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 500,000 | $6,400,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 617,100 | $6,023,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 158,200 | $5,983,000 | thousands by filing date | |
| HORIZON PHARMA PLC | G4617B105 | SHS | 400,000 | $5,840,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 185,000 | $4,991,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 50,000 | $4,736,000 | thousands by filing date | |
| AQUINOX PHARMACEUTICALS INC | 03842B101 | COM | 400,000 | $4,704,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 500,000 | $4,515,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 65,000 | $3,643,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 21,537 | $3,547,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 150,000 | $3,522,000 | thousands by filing date | |
| Rocket Pharmaceuticals Inc | 45780V102 | SHS | 1,300,000 | $3,393,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 175,000 | $3,364,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 825,000 | $3,201,000 | thousands by filing date | |
| NEOS THERAPEUTICS INC | 64052L106 | COM | 300,000 | $3,060,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 100,000 | $2,781,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 700,000 | $2,534,000 | thousands by filing date | |
| ABLYNX NV | 00372Y105 | SPONSORED ADR | 90,000 | $2,249,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 550,000 | $2,151,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 500,000 | $2,085,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 65,000 | $1,997,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS PLC | G63637105 | SHS | 200,000 | $1,196,000 | thousands by filing date | |
| CURRENCYSHS BRIT POUND STER | 23129S106 | BRIT POUND STE | 9,100 | $1,194,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 25,000 | $727,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-18-000604 | this filing | 2018-02-14 | acceptance time not in the bulk data set |